Notice of NIDDK's Participation in PA-17-147 "Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44)"

Notice Number: NOT-DK-17-010

Key Dates
Release Date:   February 9, 2017

Related Announcements
PA-17-147

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

This Notice informs potential applicants that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is participating in PA-17-147, "Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44)".

The following changes have been made to reflect NIDDK's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations
National Institute of Mental Health (NIMH)
National Cancer Institute (NCI)
National Eye Institute (NEI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute on Drug Abuse (NIDA)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of General Medical Sciences (NIGMS)
National Center for Complementary and Integrative Health (NCCIH)
National Center for Advancing Translational Sciences (NCATS)

Inquiries

Please direct all inquiries to:

Guillermo Arreaza-Rubin, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-4724
Email: arreazag@mail.nih.gov